HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ribet, M. Articles by Dambron, P. Search for Related Content PubMed PubMed Citation Articles by Ribet, M. Articles by Dambron, P.

European Journal of Cardio-Thoracic Surgery, Vol 2, 261-264, Copyright © 1988 by European Association for Cardio-thoracic Surgery

ARTICLES

Lympho-epithelial thymomas. A retrospective study of 88 resections

M Ribet, C Voisin, FR Pruvot, P Ramon and P Dambron
Surgical Clinic, Albert Calmette Hospital, Lille, France.

Of 113 lympho-epithelial thymomas retrospectively studied, 56 were epithelial, 20 lymphocytic, 30 mixed and 7 were undefined forms. There were 88 resections (20 stage I, 47 stage II, 13 stage III and 8 stage IV). There were 69 primary resections (followed by radiotherapy in 54 cases) of which 57 were complete and 12 were incomplete. There were 19 secondary resections after radiotherapy: 10 were complete and 9 were incomplete and 25 patients were not operated upon and were treated by radio- and chemotherapy. After primary resection, the actuarial 5-year survival is 64.07% and the 10-year survival is 50.86%. After a secondary resection, the 5 year-survival is 43.74%. After non-surgical treatment, it is 18.67%. After surgery, the prognostic importance of staging is confirmed as more important than the cellular structure. Myasthenic patients are subject to late accidents. Postoperative radiotherapy seems to be justified, but its effect is not statistically significant when resection is complete. Post-radiotherapy surgery is beneficial only in cases of complete resection. The metastatic evolution of thymomas has been underrated and seems to depend upon the local control of the tumour. The use of chemotherapy remains to be defined.

This article has been cited by other articles:

				F. C. Detterbeck and A. M. Parsons Thymic tumors Ann. Thorac. Surg., May 1, 2004; 77(5): 1860 - 1869. [Abstract] [Full Text] [PDF]

				E. Ruffini, M. Mancuso, A. Oliaro, C. Casadio, A. Cavallo, R. Cianci, P. L. Filosso, M. Molinatti, C. Porrello, N. Cappello, et al. RECURRENCE OF THYMOMA: ANALYSIS OF CLINICOPATHOLOGIC FEATURES, TREATMENT, AND OUTCOME J. Thorac. Cardiovasc. Surg., January 1, 1997; 113(1): 55 - 63. [Abstract] [Full Text]